Skip to main content
Erschienen in: International Journal of Hematology 6/2022

28.01.2022 | Case Report

Paravertebral extramedullary hematopoiesis in a case of myelodysplastic syndrome with ring sideroblasts and an SF3B1 mutation

verfasst von: Chie Asou, Tomoya Maeda, Maho Ishikawa, Daisuke Okamura, Mika Kohri, Naoki Takahashi, Kunihiro Tsukasaki, Hirozo Sakaguchi, Tsugumi Satoh, Hidekazu Kayano, Akira Matsuda, Norio Asou

Erschienen in: International Journal of Hematology | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

We present the case of a 56-year-old male patient with paravertebral extramedullary hematopoiesis (EMH) secondary to myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia. In a routine health checkup over 5 years prior, he presented with asymptomatic mild anemia and a posterior mediastinal mass. Pathological and cytomorphological findings of the resected paravertebral mass were similar to those of his bone marrow specimen, and included cellularity with erythroid hyperplasia, multilineage dysplastic changes, and the presence of ring sideroblasts. A concordant SF3B1 mutation was detected in both bone marrow and paravertebral mass samples, suggesting that the EMH cells were derived from the bone marrow.
Literatur
1.
Zurück zum Zitat Koch CA, Li CY, Mesa RA, Tefferi A. Nonhepatosplenic extramedullary hematopoiesis: associated diseases, pathology, clinical course, and treatment. Mayo Clin Proc. 2003;78:1223–33.CrossRef Koch CA, Li CY, Mesa RA, Tefferi A. Nonhepatosplenic extramedullary hematopoiesis: associated diseases, pathology, clinical course, and treatment. Mayo Clin Proc. 2003;78:1223–33.CrossRef
2.
Zurück zum Zitat Haidar R, Mhaidli H, Taher AT. Paraspinal extramedullary hematopoiesis in patients with thalassemia intermedia. Eur Spine J. 2010;19:871–8.CrossRef Haidar R, Mhaidli H, Taher AT. Paraspinal extramedullary hematopoiesis in patients with thalassemia intermedia. Eur Spine J. 2010;19:871–8.CrossRef
3.
Zurück zum Zitat Sohawon D, Lau KK, Lau T, Bowden DK. Extra-medullary haematopoiesis: a pictorial review of its typical and atypical locations. J Med Imaging Radiat Oncol. 2012;56:538–44.CrossRef Sohawon D, Lau KK, Lau T, Bowden DK. Extra-medullary haematopoiesis: a pictorial review of its typical and atypical locations. J Med Imaging Radiat Oncol. 2012;56:538–44.CrossRef
4.
Zurück zum Zitat Fan N, Lavu S, Hanson CA, Tefferi A. Extramedullary hematopoiesis in the absence of myeloproliferative neoplasm: Mayo Clinic case series of 309 patients. Blood Cancer J. 2018;8:119.CrossRef Fan N, Lavu S, Hanson CA, Tefferi A. Extramedullary hematopoiesis in the absence of myeloproliferative neoplasm: Mayo Clinic case series of 309 patients. Blood Cancer J. 2018;8:119.CrossRef
5.
Zurück zum Zitat Satoh T, Kayano H. Myelodysplastic syndrome with ring sideroblasts presenting as postmediastinal extramedullary hematopoiesis. Blood. 2020;136:1213.CrossRef Satoh T, Kayano H. Myelodysplastic syndrome with ring sideroblasts presenting as postmediastinal extramedullary hematopoiesis. Blood. 2020;136:1213.CrossRef
6.
Zurück zum Zitat Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405.CrossRef Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405.CrossRef
7.
Zurück zum Zitat Malcovati L, Papaemmanuil E, Bowen DT, Boultwood J, Della Porta MG, Pascutto C, et al. Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms. Blood. 2011;118:6239–46.CrossRef Malcovati L, Papaemmanuil E, Bowen DT, Boultwood J, Della Porta MG, Pascutto C, et al. Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms. Blood. 2011;118:6239–46.CrossRef
8.
Zurück zum Zitat Dibbern DA Jr, Loevner LA, Lieberman AP, Salhany KE, Freese A, Marcotte PJ. MR of thoracic cord compression caused by epidural extramedullary hematopoiesis in myelodysplastic syndrome. Am J Neuroradiol. 1997;18:363–6.PubMedPubMedCentral Dibbern DA Jr, Loevner LA, Lieberman AP, Salhany KE, Freese A, Marcotte PJ. MR of thoracic cord compression caused by epidural extramedullary hematopoiesis in myelodysplastic syndrome. Am J Neuroradiol. 1997;18:363–6.PubMedPubMedCentral
9.
Zurück zum Zitat Heffez DS, Sawaya R, Udvarhelyi GB, Mann R. Spinal epidural extramedullary hematopoiesis with cord compression in a patient with refractory sideroblastic anemia. Case report. J Neurosurg. 1982;57:399–406.CrossRef Heffez DS, Sawaya R, Udvarhelyi GB, Mann R. Spinal epidural extramedullary hematopoiesis with cord compression in a patient with refractory sideroblastic anemia. Case report. J Neurosurg. 1982;57:399–406.CrossRef
10.
Zurück zum Zitat Martinez-Losada C, Alhambra-Exposito MR, Sanchez-Sanchez R, Casaño J, Tenorio-Jimenez C, Sanchez-Garcia J. Dysplastic extramedullary haematopoeisis with ringed sideroblasts mimicking adrenal adenoma. Histopathology. 2013;63:738–9.PubMed Martinez-Losada C, Alhambra-Exposito MR, Sanchez-Sanchez R, Casaño J, Tenorio-Jimenez C, Sanchez-Garcia J. Dysplastic extramedullary haematopoeisis with ringed sideroblasts mimicking adrenal adenoma. Histopathology. 2013;63:738–9.PubMed
11.
Zurück zum Zitat Sugimoto Y, Nishii K, Sakakura M, Araki H, Usui E, Lorenzo VF, et al. Acute myeloid leukemia with t(8;21)(q22;q22) manifesting as granulocytic sarcomas in the rhinopharynx and external acoustic meatus at relapse after high-dose cytarabine: case report and review of the literature. Hematol J. 2004;5:84–9.CrossRef Sugimoto Y, Nishii K, Sakakura M, Araki H, Usui E, Lorenzo VF, et al. Acute myeloid leukemia with t(8;21)(q22;q22) manifesting as granulocytic sarcomas in the rhinopharynx and external acoustic meatus at relapse after high-dose cytarabine: case report and review of the literature. Hematol J. 2004;5:84–9.CrossRef
12.
Zurück zum Zitat Buccisano F, Maurillo L, Neri B, Masala S, Mauriello A, Del Principe MI, et al. Thoracic cord compression caused by epidural extramedullary hematopoiesis during erythroid-stimulating agent therapy in two patients with myelodysplastic syndromes. J Clin Oncol. 2013;31:e189–91.CrossRef Buccisano F, Maurillo L, Neri B, Masala S, Mauriello A, Del Principe MI, et al. Thoracic cord compression caused by epidural extramedullary hematopoiesis during erythroid-stimulating agent therapy in two patients with myelodysplastic syndromes. J Clin Oncol. 2013;31:e189–91.CrossRef
13.
Zurück zum Zitat Sawada H, Higuchi T, Koyamada R, Okada S. Myelodysplastic syndrome developing presacral extramedullary hematopoiesis with atypical MRI findings. Intern Med. 2017;56:1213–7.CrossRef Sawada H, Higuchi T, Koyamada R, Okada S. Myelodysplastic syndrome developing presacral extramedullary hematopoiesis with atypical MRI findings. Intern Med. 2017;56:1213–7.CrossRef
14.
Zurück zum Zitat Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature. 2011;478:64–9.CrossRef Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature. 2011;478:64–9.CrossRef
15.
Zurück zum Zitat Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D, et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med. 2011;365:1384–95.CrossRef Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D, et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med. 2011;365:1384–95.CrossRef
16.
Zurück zum Zitat Venable ER, Chen D, Chen CP, Bessonen KR, Nguyen PL, Oliveira JL, et al. Pathologic spectrum and molecular landscape of myeloid disorders harboring SF3B1 mutations. Am J Clin Pathol. 2021;156:679–90.CrossRef Venable ER, Chen D, Chen CP, Bessonen KR, Nguyen PL, Oliveira JL, et al. Pathologic spectrum and molecular landscape of myeloid disorders harboring SF3B1 mutations. Am J Clin Pathol. 2021;156:679–90.CrossRef
17.
Zurück zum Zitat Malcovati L, Stevenson K, Papaemmanuil E, Neuberg D, Bejar R, Boultwood J, et al. SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS. Blood. 2020;136:157–70.CrossRef Malcovati L, Stevenson K, Papaemmanuil E, Neuberg D, Bejar R, Boultwood J, et al. SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS. Blood. 2020;136:157–70.CrossRef
18.
Zurück zum Zitat Konoplev S, Hsieh PP, Chang CC, Medeiros LJ, Lin P. Janus kinase 2 V617F mutation is detectable in spleen of patients with chronic myeloproliferative diseases suggesting a malignant nature of splenic extramedullary hematopoiesis. Hum Pathol. 2007;38:1760–3.CrossRef Konoplev S, Hsieh PP, Chang CC, Medeiros LJ, Lin P. Janus kinase 2 V617F mutation is detectable in spleen of patients with chronic myeloproliferative diseases suggesting a malignant nature of splenic extramedullary hematopoiesis. Hum Pathol. 2007;38:1760–3.CrossRef
Metadaten
Titel
Paravertebral extramedullary hematopoiesis in a case of myelodysplastic syndrome with ring sideroblasts and an SF3B1 mutation
verfasst von
Chie Asou
Tomoya Maeda
Maho Ishikawa
Daisuke Okamura
Mika Kohri
Naoki Takahashi
Kunihiro Tsukasaki
Hirozo Sakaguchi
Tsugumi Satoh
Hidekazu Kayano
Akira Matsuda
Norio Asou
Publikationsdatum
28.01.2022
Verlag
Springer Nature Singapore
Erschienen in
International Journal of Hematology / Ausgabe 6/2022
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-022-03291-2

Weitere Artikel der Ausgabe 6/2022

International Journal of Hematology 6/2022 Zur Ausgabe

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.